miRNA‐15a, miRNA‐16, miRNA‐126, miRNA‐146a, and miRNA‐223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment

Authors:

Abstract
Objective: MicroRNAs engaged in angiogenesis and hematopoiesis can influence hematopoietic stem cells (HSCs) homing after transplantation by targeting bone marrow niche microenvironment. This study aimed to examine the kinetics of miRNA‐15a, miRNA‐16, miRNA‐126, miRNA‐146a, and miRNA‐223 in autologous HSC transplantation settings.Methods: The study comprised of 51 patients with hematological malignancies (42 multiple myeloma, 9 lymphoma). Samples were taken at four time points: before conditioning, after chemotherapy but prior to autologous HSC transplantation (day 0), on day +7, and +14 days after HSCT. The miRNA levels were evaluated by the real‐time PCR method.Results: A significant, steady decline of all tested microRNAs in the course of transplantation, as compared to the baseline, was found. The study revealed that higher levels of miRNA‐15a, miRNA‐16, miRNA‐126, and miRNA‐146a on day 0 correlated with longer time to engraftment. Additionally, a positive correlation between the levels of miRNA‐15a, miRNA‐146a, and miRNA‐223 assessed on day +7 and the time to engraftment was observed.Conclusions: In conclusion, all investigated microRNAs changed significantly in the course of transplantation. Our results suggest that the miRNAs may participate in hematopoietic recovery in the early post‐transplant period and influence engraftment efficiency after HSCT.
Funding Information
  • Uniwersytet Medyczny w Lodzi (502-03/1-093-01/502-14-289, 503/1-093-01/503-11-001, 507-60-022)

This publication has 53 references indexed in Scilit: